Next Article in Journal
One-Year Functional Evaluation of Patient After CD34+ Stem Cell Treatment for Hip Osteoarthritis
Next Article in Special Issue
Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Ischemic Stroke
Previous Article in Journal
Exploring Biomarkers for Excess Extracellular Fluid in the Context of Physical Function in Chronic Kidney Disease Patients
Previous Article in Special Issue
Revolutionizing Sleep Health: The Emergence and Impact of Personalized Sleep Medicine
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 14
Issue 12
10.3390/jpm14121125
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Long-Term Safety and Efficacy of Lacosamide Combined with NOACs in Post-Stroke Epilepsy and Atrial Fibrillation: A Prospective Longitudinal Study

by
Marilena Mangiardi
1,*,†,
Francesca Romana Pezzella
1,†,
Alessandro Cruciani
2,
Michele Alessiani
3 and
Sabrina Anticoli
1
1
Department of Stroke Unit, San Camillo-Forlanini Hospital, 00152 Rome, Italy
2
Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine, Campus Bio-Medico University, 00128 Rome, Italy
3
Neurology Division S. Maria Goretti Hospital, 04100 Latina, Italy
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work and share first authorship.
J. Pers. Med. 2024, 14(12), 1125; https://doi.org/10.3390/jpm14121125
Submission received: 24 September 2024 / Revised: 12 November 2024 / Accepted: 19 November 2024 / Published: 27 November 2024
(This article belongs to the Special Issue New Advances in the Prevention and Treatment of Neurological Diseases)
Browse Figures
Versions Notes

Abstract

Background and Aims: Stroke is the leading cause of seizures and epilepsy in adults; however, current guidelines lack robust recommendations for treating post-stroke seizures (PSSs) and epilepsy (PSE). This study aims to demonstrate the long-term safety and efficacy of lacosamide combined with non-vitamin K antagonist oral anticoagulants (NOACs) in patients with PSE and atrial fibrillation (AF). Methods: In this prospective longitudinal single-center study, 53 patients with concomitant PSE and AF, admitted between 2022 and 2023, received NOACs for AF management and lacosamide for seizure control. A control group of 53 patients with cardioembolic stroke, receiving NOACs (but without PSE), was matched by age, sex, and NIHSS scores to ensure comparability. Results: Over 24 months, 16 patients in the study group and 15 in the control group experienced new embolic events, with no significant difference between groups (p = 0.82). Seizure control improved significantly in the study group, with reduced frequency and severity. No severe adverse events from lacosamide were observed. Conclusions: The combination of NOACs and lacosamide is a safe and effective treatment for patients with AF and PSE and does not increase the risk of recurrent ischemic or hemorrhagic events. Further studies with larger sample sizes and longer follow-ups are needed to confirm these findings and optimize treatment protocols.
Keywords: atrial fibrillation; post-stroke epilepsy; post-stroke seizures; ischemic stroke; non-vitamin K antagonist oral anticoagulants (NOACs) atrial fibrillation; post-stroke epilepsy; post-stroke seizures; ischemic stroke; non-vitamin K antagonist oral anticoagulants (NOACs)

Share and Cite

MDPI and ACS Style

Mangiardi, M.; Pezzella, F.R.; Cruciani, A.; Alessiani, M.; Anticoli, S. Long-Term Safety and Efficacy of Lacosamide Combined with NOACs in Post-Stroke Epilepsy and Atrial Fibrillation: A Prospective Longitudinal Study. J. Pers. Med. 2024, 14, 1125. https://doi.org/10.3390/jpm14121125

AMA Style

Mangiardi M, Pezzella FR, Cruciani A, Alessiani M, Anticoli S. Long-Term Safety and Efficacy of Lacosamide Combined with NOACs in Post-Stroke Epilepsy and Atrial Fibrillation: A Prospective Longitudinal Study. Journal of Personalized Medicine. 2024; 14(12):1125. https://doi.org/10.3390/jpm14121125

Chicago/Turabian Style

Mangiardi, Marilena, Francesca Romana Pezzella, Alessandro Cruciani, Michele Alessiani, and Sabrina Anticoli. 2024. "Long-Term Safety and Efficacy of Lacosamide Combined with NOACs in Post-Stroke Epilepsy and Atrial Fibrillation: A Prospective Longitudinal Study" Journal of Personalized Medicine 14, no. 12: 1125. https://doi.org/10.3390/jpm14121125

APA Style

Mangiardi, M., Pezzella, F. R., Cruciani, A., Alessiani, M., & Anticoli, S. (2024). Long-Term Safety and Efficacy of Lacosamide Combined with NOACs in Post-Stroke Epilepsy and Atrial Fibrillation: A Prospective Longitudinal Study. Journal of Personalized Medicine, 14(12), 1125. https://doi.org/10.3390/jpm14121125

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop